Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity.
|
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
FLXEf2Afbpqv1HJZ